Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
about
Therapeutic interference with leukocyte recirculation in multiple sclerosis.Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human TissuesLong-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab
P2860
Q30884219-34482AE1-B8F8-4812-A264-0AB39AFF762CQ33975585-7574A77B-9D4E-4EEE-A0D1-FC2AF76A6F1CQ36394016-91AC8353-DE79-459B-8882-46B908CDF086Q38795434-B4A2392A-F095-4329-9676-4A3FA6EE2845Q39668327-5D7E067B-607B-4E8E-A573-30F82E2062C0Q42266048-0F48B89A-17BB-4BBA-A441-88C91FD22CD8Q42732611-20291768-91A2-4E36-B054-4B5E6B96B7A6Q47102132-AA3F7A41-7834-4B25-8DAF-E4FDBC82FBDEQ49884884-23067E11-5F1A-436E-97BF-25296476444CQ50640109-0632548C-F5B2-40E8-B9FA-B9D962E0FCC2Q58572875-DEEB86FA-9197-4B64-82F6-78BAAEA755EAQ59154932-6094E7FD-E441-477B-9AC7-F5061E2B7109
P2860
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@ast
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@en
type
label
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@ast
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@en
prefLabel
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@ast
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@en
P2093
P2860
P1433
P1476
Increased B cell and cytotoxic ...... d multiple sclerosis patients.
@en
P2093
Charlotte Dahle
Jan Ernerudh
Johan Mellergård
Magnus Vrethem
Maria C Jenmalm
Måns Edström
P2860
P304
P356
10.1371/JOURNAL.PONE.0081685
P407
P577
2013-12-02T00:00:00Z